WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $14.31 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.